A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors

Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan

(2014) Masaaki Mori et al.   Modern Rheumatology

Brief Report: Incidence of Selected Opportunistic Infections Among Children With Juvenile Idiopathic Arthritis

(2013) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM

Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor-  Inhibitors: Systematic Review of the Literature

(2013) S. S. Toussi et al.   CLINICAL INFECTIOUS DISEASES

Infectious Complications in Juvenile Idiopathic Arthritis

(2013) Andrew Hurd et al.   Current Rheumatology Reports

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

(2012) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM

Safety and Efficacy of Etanercept in a Cohort of Patients with Juvenile Idiopathic Arthritis Under 4 Years of Age

(2012) C. BRACAGLIA et al.   JOURNAL OF RHEUMATOLOGY

High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis

(2011) K. Au et al.   ANNALS OF THE RHEUMATIC DISEASES

Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?

(2011) Omer Kilic et al.   RHEUMATOLOGY INTERNATIONAL

The safety profile of biologic therapies for juvenile idiopathic arthritis

(2010) Philip J. Hashkes et al.   Nature Reviews Rheumatology

Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis

(2009) E. H. Giannini et al.   ARTHRITIS AND RHEUMATISM

The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis

(2009) Johan Askling et al.   CURRENT OPINION IN RHEUMATOLOGY

The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis

(2009) Daniel E. Furst   SEMINARS IN ARTHRITIS AND RHEUMATISM

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

(2008) G Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

(2008) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM

Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha

(2008) Osman Elbek et al.   CLINICAL RHEUMATOLOGY

Association of infections and tuberculosis with antitumor necrosis factor alpha therapy

(2008) Nivedita M Patkar et al.   CURRENT OPINION IN RHEUMATOLOGY

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Focus on adverse events of tumour necrosis factor   blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients

(2007) V Gerloni et al.   ANNALS OF THE RHEUMATIC DISEASES